Drug Profile
Research programme: dopamine receptor agonists - DarPharma
Alternative Names: DAR 0300Latest Information Update: 30 Jul 2015
Price :
$50
*
At a glance
- Originator DarPharma
- Class Small molecules
- Mechanism of Action Dopamine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Attention-deficit hyperactivity disorder; Autistic disorder; Male sexual dysfunction; Restless legs syndrome
Most Recent Events
- 29 Jun 2004 Preclinical trials in Attention-deficit hyperactivity disorder in USA (unspecified route)
- 29 Jun 2004 Preclinical trials in Autism in USA (unspecified route)
- 29 Jun 2004 Preclinical trials in Male sexual dysfunction in USA (unspecified route)